A Phase 1 interventional study of ERAS and Traditional measures in Enhanced Recovery After Surgery, sponsored by Shanghai Zhongshan Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-09-05.
Sponsored by Shanghai Zhongshan Hospital · Phase 1, Interventional, and Prevention
This is a single center, randomized,single blind study to investigate the effectiveness of enhanced recovery regimen (ERAS) in patients undergoing Video-assisted Mediastinal Surgery. And we also going to compare the effectiveness of ERAS with that of traditional regimen in these patients.
Compare to traditional measures, the ERAS protocal mainly includes:Good preoperative visit, shorten the fast time, minimumal invasive surgery procedures, fewer opioids and early movements after surgery. These items have been successfully used in colon cancer surgery, and we thus plan to investigate the effectiveness of these measures in mediastinal surgery.
Exclusion Criteria:
The patients in this group receive enhanced measures perioperatively
Combination Product: ERAS
The patients in this group receive traditional measures perioperatively
Combination Product: Traditional measures
The investigators mainly used enhanced measures perioperatively in mediastinal surgery as these used in other surgery
The investigators mainly used traditional measures perioperatively in mediastinal surgery as these used in other surgery
15-item quality of recovery scale (QoR-15)
This scale mainly reflects the patient's status
Time frame: At preoperative vist
15-item quality of recovery scale (QoR-15)
This scale mainly reflects the patient's status
Time frame: At 24 hours after surgery
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Zhongshan Hospital